首页> 外国专利> Matrix tablets with the fundamentals of sustained release TRIMETAZIDINE dihydrochloride, PROCESS FOR ITS PREPARATION AND METHOD OF TREATMENT

Matrix tablets with the fundamentals of sustained release TRIMETAZIDINE dihydrochloride, PROCESS FOR ITS PREPARATION AND METHOD OF TREATMENT

机译:具有缓释曲美他定二盐酸盐基本原理的基质片剂,其制备方法和治疗方法

摘要

FIELD: medicine; pharmaceutics.;SUBSTANCE: invention concerns a matrix tablet with a basis for the prolonged trimetazidine or its pharmaceutically comprehensible salt release, (rather, trimetazidine dihydrochloride), possessing membrane stabilising, cytoprotective, antihypoxant and antioxidatic activity containing the combination of hydroxypropyl cellulose and copovidone, at their quantitative parity 20.0-24.7 wt % and 1.3-8.0 wt % in quality of a matrix forming component, way of its reception, way of treatment or prevention of conditions at which introduction of antioxidants is necessary, antihypoxants, cytoprotectors and membrane stabilisers. The offered invention provides optimum quantitative and qualitative structure of components for manufacturing of solid peroral medicinal forms of trimetazidine or its pharmaceutically comprehensible salt of the prolonged action, not rendering allergenic and toxic action, providing gradual and prolonged liberation of the agent during the long period of time.;EFFECT: stable maintenance of effective concentration of trimetazidine in a blood plasma throughout the long period of time.;16 cl, 1 ex, 1 tbl, 1 dwg
机译:领域:医学;发明内容本发明涉及一种基质片剂,其具有延长的曲美他嗪或其药学上可接受的盐释放的基础(而是曲美他嗪二盐酸盐),具有膜稳定,细胞保护,抗氧和抗氧化活性,包含羟丙基纤维素和共聚维酮的组合,以其形成基质的组分的质量分别为20.0-24.7 wt%和1.3-8.0 wt%的比例,其接受方式,治疗或预防需要引入抗氧化剂的条件,抗氧化剂,细胞保护剂和膜稳定剂的量。所提供的发明提供了用于制造曲美他嗪或其口服可药用盐的固体口服药物形式的最佳定量和定性结构,其延长作用而不产生变态反应和毒性作用,从而在长时间的使用中逐渐和长期释放药剂。效果:长期稳定维持血浆中曲美他嗪的有效浓度。; 16 cl,1 ex,1 tbl,1 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号